Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

C4 Therapeutics (CCCC) Return on Assets (2020 - 2025)

C4 Therapeutics (CCCC) has 6 years of Return on Assets data on record, last reported at 0.34% in Q4 2025.

  • For Q4 2025, Return on Assets fell 5.0% year-over-year to 0.34%; the TTM value through Dec 2025 reached 0.34%, down 5.0%, while the annual FY2025 figure was 0.3%, 1.0% down from the prior year.
  • Return on Assets reached 0.34% in Q4 2025 per CCCC's latest filing, up from 0.42% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.17% in Q4 2021 and bottomed at 0.42% in Q3 2025.
  • Average Return on Assets over 5 years is 0.28%, with a median of 0.29% recorded in 2022.
  • Peak YoY movement for Return on Assets: fell -17bps in 2023, then rose 10bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.17% in 2021, then plummeted by -72bps to 0.28% in 2022, then plummeted by -31bps to 0.37% in 2023, then grew by 22bps to 0.29% in 2024, then dropped by -16bps to 0.34% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.34% in Q4 2025, 0.42% in Q3 2025, and 0.36% in Q2 2025.